This paper aims to provide some remarks on Decree No. 232/2023, which concerns insurance and other risk financing tools aimed at adequately compensating patients in cases of malpractice claims. The objective is to assess whether the regulatory framework aligns with the institutional choices made in terms of public policy goals. Following a brief description of the main features of the Decree, the paper concludes with some reflections on the solvency of healthcare facilities.
Brevi riflessioni a margine del Decreto 15 novembre 2023, n. 232 in punto di «analoghe misure»
velliscig
2024-01-01
Abstract
This paper aims to provide some remarks on Decree No. 232/2023, which concerns insurance and other risk financing tools aimed at adequately compensating patients in cases of malpractice claims. The objective is to assess whether the regulatory framework aligns with the institutional choices made in terms of public policy goals. Following a brief description of the main features of the Decree, the paper concludes with some reflections on the solvency of healthcare facilities.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
